Caribou Biosciences: 2 Clinical Data Updates In 2024 Could Bring Value

1d ago, source:

Caribou Biosciences, Inc. expects promising phase 1 studies on CB-010 and CB-011 for various lymphoma and myeloma treatments ...

CRBU Caribou Biosciences, Inc.

16d ago, source: Seeking Alpha

Caribou Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the development of genome-edited allogeneic cell therapies for the treatment of hematologic malignancies in the ...

Caribou Biosciences Inc Ordinary Shares

2d ago, source: Morningstar

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

With 65% institutional ownership, Caribou Biosciences, Inc. (NASDAQ:CRBU) is a favorite amongst the big guns

19d ago, source: Yahoo Finance

Caribou Biosciences already has institutions on the ... Looking at our data, we can see that the largest shareholder is BlackRock, Inc. with 7.8% of shares outstanding. PFM Health Sciences ...

Kura Sushi Posts Upbeat Sales, Joins Caribou Biosciences, Krispy Kreme And Other Big Stocks Moving Higher In Friday's Pre-Market Session

on MSN ago, source:

U.S. stock futures were higher this morning, with the Dow futures gaining by around 100 points on Friday. Shares of Kura ...

Caribou Biosciences Inc (CRBU)

4d ago, source: Investing

After-Hours Stock Movers: ACADIA Pharmaceuticals Inc (NASDAQ:ACAD) 20% HIGHER; announced that it has expanded its current licensing agreement for trofinetide with Neuren ...

Caribou Biosciences Inc (CRBU)

3d ago, source: Investing

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all ...

Caribou Biosciences Inc.

29d ago, source: Barron's

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...

Caribou Biosciences Inc (CRBU)

1mon ago, source: Investing

Caribou Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the development of genome-edited allogeneic cell therapies for the treatment of hematologic malignancies in the United ...